CIK 0000907654 · Non-accelerated filer<br>Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363855489
- Phone
- 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Item 5 · Item 7
- 8-K Event Item 5 · Item 7
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K/A Event Item 4 · Item 7
- 10-Q Report Quarterly Report
- 8-K Event Item 4 · Item 7
- 8-K/A Event Item 4 · Item 7
- 8-K Event Item 4 · Item 7
- SC 13D/A Stake Beneficial Ownership Report
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-K405 Other 10-K405
- 8-K/A Event Item 5 · Item 7
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Item 5
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
Page 75 of 77 · 1,539 filings